Three years ago, the Global Vaccine Data Network (“GVDN”) was granted unfettered access to health records by numerous governments. Yet, GVDN has failed to produce any full and meaningful analysis of covid vaccine injuries.
There is a need for a comprehensive health service audit, Dr. Guy Hatchard says. “It is time for governments to insist that health services provide them with up-to-date information on the extent of healthcare usage and all-cause mortality, and that also needs to be related to covid vaccine status.”
What is GVDN?
GVDN is a global partnership to monitor the safety and effectiveness of vaccines across hundreds of millions of people rather than just the tens of thousands involved in large clinical trials. GVDN covers 31 sites in 26 countries across six continents, representing more than 300 million people.
It is a member of the World Health Organisation’s (“WHO’s”) Vaccine Safety Net which means it has been evaluated by WHO and meets WHO’s Global Advisory Committee on Vaccine Safety (“GACVS”) criteria for “good information practices.”
GVDN received seeding money from the Gates Foundation in 2019. According to an extract from a GACVS meeting in June 2019:
GACVS was informed about a new global vaccine data network (GVDN) … An inaugural meeting was held in Annecy (France) in January 2018* … Representatives from academia, research centres, industry and GAVI in 16 countries in all 6 WHO regions attended.
[Note: GVDN’s website states that the inaugural meeting was held in January 2019.]
The meeting reached agreement on a collaborative model for conducting studies of vaccine safety, efficacy and risk-benefit; a governance model that ensures full participation of sites and efficient development of study protocols; data models to protect individual privacy but allow collaborative agreements on common data models (standardisation of data to allow pooling of results); and a pilot study to investigate the link between influenza vaccines and Guillain–Barré syndrome.
The advantages for countries would be access to the entire GVDN. [GACVS] also considered that the regulatory imperative for post-licensure surveillance could sustain support for a GVDN through a common pool. The requirement for this type of active surveillance in GAVI-eligible countries as a condition for receiving vaccines could drive capacity-building in those countries.Use of distributed data networks, World Health Organisation, 2019
In April 2021, the GVDN received significant funding from the US Centres for Disease Control and Prevention (“CDC”) for the project over three years, entitled Global Covid Vaccine Safety (“GCoVS”). In August 2022, the CDC granted additional funding to extend the GCoVS project by two years and expand the number of sites participating globally.
GVDN relies on research grants for specific vaccine safety monitoring projects and is hosted by UniServices, a not-for-profit stand-alone company that is wholly owned by the University of Auckland. Funding for New Zealand-focused research has been received from Te Whatu Ora Health New Zealand, previously the New Zealand Ministry of Health.